Vanessa Yap, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 170 Grandview Ave, Waterbury, CT 06708 Phone: 203-759-3666 Fax: 203-759-5005 |
Richard S. Silverman, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 170 Grandview Avenue, Waterbury, CT 06708 Phone: 203-759-3666 Fax: 203-759-3671 |
Dr. Arthur Christian Degraff Jr., M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 160 Hunter Dr, West Hartford, CT 06107 Phone: 860-521-8954 Fax: 860-521-8954 |
Dr. John Gayloard Teeter, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 Fax: 203-937-4748 |
Carlos Fragoso, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, Mailcode 151b, West Haven, CT 06516 Phone: 203-932-5711 Fax: 203-937-4932 |
Steven A Thau, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1505 Post Rd E Ste 100, Westport, CT 06880 Phone: 203-221-3370 Fax: 203-221-3380 |
Marlene Schwartz, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 112 Mansfield Ave, Pulmonary Disease Division, Hatch Wing, Willimantic, CT 06226 Phone: 860-456-7279 Fax: 860-450-0269 |
Nagireddy Kamireddy, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 96 Mansfield Ave, Willimantic, CT 06226 Phone: 860-450-7583 |
Dr. Robert Joseph Bundy, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 112 Mansfield Ave, Pulmonary Dept., Hatch Wing, Willimantic, CT 06226 Phone: 860-456-7279 Fax: 860-450-0269 |
Johan Van Jaarsveld, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 81 Deer Run Rd, Woodbridge, CT 06525 Phone: 281-460-9533 |
News Archive
Understanding the structure of proteins is a vital first step in developing new drugs, but to date, researchers have had difficulty studying the large number of proteins that are normally embedded in the cell membrane, a family of proteins that includes those involved in cancer-related signaling processes.
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, notes that its development partner, Tibotec Pharmaceuticals, has announced the results of a Week-24 planned interim analysis of the Phase 2 response-guided PILLAR study for TMC435, Medivir's key pipeline asset, a hepatitis C protease inhibitor dosed once-daily.
The findings reveal that the variant has considerably higher transmissibility and immune escape potential than previously circulating variants and that it can increase the infection fatality rate by 62% - 82% among older adults. The study is currently available on the medRxiv* preprint server.
Now, a team of researchers at Rice University, Baylor College of Medicine, and the Houston Health Department show SARS-CoV-2 RNA wastewater levels to be a strong predictive of trends in the nasal positivity rate two weeks in advance. This could help track the positivity rate for populations, speeding up the isolation and treatment of infected people.
› Verified 3 days ago